Cevik 2008.
Methods | Case‐control study | |
Participants | 25 confirmed cases Age NR, Sex NR | |
Interventions | Ribavirin loading dosage of 17 mg/kg IV, then 17 mg/kg every 6 h for 4 days, and then 8 mg/kg every 8 h for 6 days Intravenous administration | |
Outcomes | Mortality, SAEs, length of hospitalisation, treatment discontinuation, requirement for transfusion (PRC, FFP, platelets) | |
Location and dates | Ankara Numune Education and Research Hospital and Sivas Cumhuriyet University Hospital, Ankara, Turkey May ‐ August 2006 | |
Number of days since onset of symptoms (mean/SD) | NR | |
Supportive therapy | NR | |
Notes |